Sutro Biopharma (STRO) Shares Issued (2018 - 2025)
Sutro Biopharma recorded quarterly Shares Issued of $4000.0 in Q4 2025, up 101.63% quarter-over-quarter from -$246000.0 in Q2 2025, and up 100.02% year-over-year from $1999.8 in Q4 2024.
Sutro Biopharma's Shares Issued history runs 8 years deep, the most recent figure standing at $4000.0 for Q4 2025.
- In Q4 2025, Shares Issued rose 100.02% year-over-year to $4000.0; the TTM figure through Dec 2025 stood at $4000.0 (up 100.01% YoY), while the FY2025 annual figure was $4000.0, down 98.52% from the prior year.
- Shares Issued came in at $4000.0 for Q4 2025 at Sutro Biopharma, up from -$246000.0 in the prior quarter.
- In the past five years, Shares Issued ranged from a high of $10.9 million in Q3 2023 to a low of -$50.0 million in Q2 2024.
- A 5-year average of -$3.8 million and a median of $246000.0 in 2025 frame the typical range for Shares Issued.
- On a YoY basis, Shares Issued climbed as much as 1761.73% in 2022 and fell as far as 4463.75% in 2022.
- Sutro Biopharma's Shares Issued stood at $513000.0 in 2021, then tumbled by 1461.01% to -$7.0 million in 2022, then surged by 255.74% to $10.9 million in 2023, then plunged by 327.41% to -$24.7 million in 2024, then jumped by 100.02% to $4000.0 in 2025.
- According to Business Quant data, Shares Issued over the past three periods registered $4000.0, -$246000.0, and $246000.0 for Q4 2025, Q2 2025, and Q1 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 5.40 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 27.00 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 163.10 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 13.16 Mn |
| 10 | Sutro Biopharma | 248.39 Mn | 248.39 Mn | - | 4,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4,000.00 |
| Dec 31, 2025 | 4,000.00 |
| Jun 30, 2025 | -246,000.00 |
| Jun 30, 2025 | -246,000.00 |
| Mar 31, 2025 | 246,000.00 |
| Mar 31, 2025 | 246,000.00 |
| Dec 31, 2024 | -24.73 Mn |
| Dec 31, 2024 | -24.73 Mn |
| Jun 30, 2024 | -50.00 Mn |
| Jun 30, 2024 | -50.00 Mn |
| Mar 31, 2024 | 911,000.00 |
| Mar 31, 2024 | 911,000.00 |
| Sep 30, 2023 | 10.87 Mn |
| Sep 30, 2023 | 10.87 Mn |
| Mar 31, 2023 | 1.10 Mn |
| Mar 31, 2023 | 1.10 Mn |
| Sep 30, 2022 | -6.98 Mn |
| Sep 30, 2022 | -6.98 Mn |
| Jun 30, 2022 | 8.42 Mn |
| Jun 30, 2022 | 8.42 Mn |
| Mar 31, 2022 | 180,000.00 |
| Mar 31, 2022 | 180,000.00 |
| Dec 31, 2021 | 513,000.00 |
| Dec 31, 2021 | 513,000.00 |
| Sep 30, 2021 | 160,000.00 |
| Sep 30, 2021 | 160,000.00 |
| Jun 30, 2021 | 452,000.00 |
| Jun 30, 2021 | 452,000.00 |
| Mar 31, 2021 | 1.36 Mn |
| Mar 31, 2021 | 1.36 Mn |
| Dec 31, 2020 | 1.69 Mn |
| Dec 31, 2020 | 1.69 Mn |
| Sep 30, 2020 | 16.80 Mn |
| Sep 30, 2020 | 16.80 Mn |
| Mar 31, 2020 | 646,000.00 |
| Mar 31, 2020 | 646,000.00 |
| Dec 31, 2019 | 47,000.00 |
| Dec 31, 2019 | 47,000.00 |
| Sep 30, 2019 | 81,000.00 |
| Sep 30, 2019 | 81,000.00 |
| Jun 30, 2019 | 10,000.00 |
| Jun 30, 2019 | 10,000.00 |
| Mar 31, 2019 | 42,000.00 |
| Mar 31, 2019 | 42,000.00 |
| Dec 31, 2018 | 10.00 Mn |
| Dec 31, 2018 | 10.00 Mn |
| Jun 30, 2018 | -38,000.00 |
| Jun 30, 2018 | -38,000.00 |
| Mar 31, 2018 | 38,000.00 |
| Mar 31, 2018 | 38,000.00 |